Health Department Andaman & Nicobar High Level Medical Device Disinfectant Tender South Andaman MDR 2017 Compliant 2026

Bidders must submit drug/device licenses under the Drugs and Cosmetics Act, GST and PAN, and turnover certificates for 2022-23 to 2024-25, plus batch MDR test reports. Include evidence of MDR 2017 compliance and manufacturing unit certification with the bid and upon delivery.

Required documents include valid drug license, reseller license if applicable, PAN, GST, CA-signed turnover certificates for 2022-23 to 2024-25, and MDR test reports. OEM authorizations may be needed plus manufacturing unit certification and device compliance certificates.

Packing size must be specified with ±10 g/mL variation, and type of packing must be defined (bottle, sachet, etc.). Ensure packaging meets MDR and shelf life requirements and aligns with batch-wise test report documentation.

Eligibility includes MDR 2017 compliance, valid drug/device licenses, PAN and GST registration, turnover proofs for 2022-23 to 2024-25, and ability to supply per original/extended delivery timelines with up to 25% quantity adjustment.

Delivery starts after the original delivery order date; if quantities increase, delivery time extends using the formula (increased quantity/original quantity) × original period, with a minimum 30 days, and possible extension up to the original delivery period.

Bid must include MDR 2017 test reports for each batch, manufacturing unit certification, and proof of drug/device licensing; submit all certifications with bid or along with supplies per buyer requirement.

Provide manufacturing unit certification and, if applicable, OEM authorization; demonstrate ability to meet shelf life and packaging requirements and supply alongside batch-wise MDR compliant test reports.

Verify MDR 2017 compliance and licensing requirements from the Health Department Andaman & Nicobar tender terms; ensure drug licenses, manufacturing licenses, and test reports are up to date prior to bid submission.